Acid-base and electrolyte abnormalities during renal support for acute kidney injury: Recognition and management

Blood Purification

Volumn 34, Issue 2, 2012, Pages 186-193

  Claure, Rolando ^a   Bouchard, Josée ^b  

^a Universidad del Valle   (Bolivia)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Acid base disorders; Dialysis; Electrolyte; Intermittent hemodialysis; Renal replacement therapy

Indexed keywords

BICARBONATE; CITRIC ACID; PAMIDRONIC ACID;

ACID BASE BALANCE; ACUTE KIDNEY FAILURE; ANTICOAGULATION; CONTINUOUS RENAL REPLACEMENT THERAPY; DIALYSIS; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAPHY; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPERKALEMIA; HYPERMAGNESEMIA; HYPERPHOSPHATEMIA; HYPOCALCEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOPHOSPHATEMIA; LACTIC ACIDOSIS; METABOLIC ACIDOSIS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; REVIEW; SYSTEMATIC REVIEW;

ACID-BASE IMBALANCE; ACIDOSIS, RESPIRATORY; ACUTE KIDNEY INJURY; ALKALOSIS, RESPIRATORY; ANTICOAGULANTS; CITRATES; HUMANS; RENAL REPLACEMENT THERAPY; WATER-ELECTROLYTE IMBALANCE;

EID: 84867942030     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000341723     Document Type: Review

References (34)

1. Claure-Del Granado RME, Soroko S, Chertow GM, Himmelfarb J, Ikizler AT, Paganini EP, Mehta RL: Assessment of metabolic acidosis in critically ill patients with acute kidney injury (AKI). J Am Soc Nephrol 2010; 21: 55A.
2. Cooper DJ, Walley KR, Wiggs BR, Russell JA: Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis. A prospective, controlled clinical study. Ann Intern Med 1990; 112: 492-498.
3. Rocktaschel J, Morimatsu H, Uchino S, Ronco C, Bellomo R: Impact of continuous venovenous hemofiltration on acid-base balance. Int J Artif Organs 2003; 26: 19-25.
4. Uchino S, Bellomo R, Ronco C: Intermittent versus continuous renal replacement therapy in the icu: Impact on electrolyte and acidbase balance. Intensive Care Med 2001; 27: 1037-1043.
5. Kierdorf HP, Leue C, Arns S: Lactate- or bicarbonate-buffered solutions in continuous extracorporeal renal replacement therapies. Kidney Int SUPPL 1999; 72:S32-S36.
6. Tan HK, Uchino S, Bellomo R: Electrolyte mass balance during CVVH: Lactate vs bicarbonate-buffered replacement fluids. Ren Fail 2004; 26: 149-153.
7. Tan HK, Uchino S, Bellomo R: The acid-base effects of continuous hemofiltration with lactate or bicarbonate buffered replacement fluids. Int J Artif Organs 2003; 26: 477-483.
8. Mehta RL, McDonald BR, Aguilar MM, Ward DM: Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990; 38: 976-981.
9. Kramer L, Bauer E, Joukhadar C, Strobl W, Gendo A, Madl C, Gangl A: Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med 2003; 31: 2450-2455.
10. Heering P, Ivens K, Thumer O, Brause M, Grabensee B: Acid-base balance and substitution fluid during continuous hemofiltration. Kidney Int SUPPL 1999; 72:S37-S40.
11. Cole L, Bellomo R, Baldwin I, Hayhoe M, Ronco C: The impact of lactate-buffered high-volume hemofiltration on acid-base balance. Intensive Care Med 2003; 29: 1113-1120.
12. Morimatsu H, Uchino S, Bellomo R, Ronco C: Continuous renal replacement therapy: Does technique influence electrolyte and bicarbonate control? Int J Artif Organs 2003; 26: 289-296.
13. Bouchard J, Mehta RL: Acid-base disturbances in the intensive care unit: Current issues and the use of continuous renal replacement therapy as a customized treatment tool. Int J Artif Organs 2008; 31: 6-14.
14. Martin WJ, Matzke GR: Treating severe metabolic alkalosis. Clin Pharm 1982; 1: 42-48.
15. Adrogue HJ, Madias NE: Hyponatremia. N Engl J Med 2000; 342: 1581-1589.
16. Kraus MA: Selection of dialysate and replacement fluids and management of electrolyte and acid-base disturbances. Semin Dial 2009; 22: 137-140.
17. Yang YF, Wu VC, Huang CC: Successful management of extreme hypernatraemia by haemofiltration in a patient with severe metabolic acidosis and renal failure. Nephrol Dial Transplant 2005; 20: 2013-2014.
18. Inagaki Y, Miyazaki T, Amano I: Peritoneal dialysis as therapy for electrolyte and acid base disorders. Int J Artif Organs 1989; 12: 632-637.
19. Van der Sande FM LN, Kooman JP: Intradialytic Complications: Pathophysiology, Prevention and Treatment, ed 5. New York, Kluwer, 2006.
20. Blumberg A, Roser HW, Zehnder C, Muller-Brand J: Plasma potassium in patients with terminal renal failure during and after haemodialysis; relationship with dialytic potassium removal and total body potassium. Nephrol Dial Transplant 1997; 12: 1629-1634.
21. Zehnder C, Gutzwiller JP, Huber A, Schindler C, Schneditz D: Low-potassium and glucosefree dialysis maintains urea but enhances potassium removal. Nephrol Dial Transplant 2001; 16: 78-84.
22. Hou S, McElroy PA, Nootens J, Beach M: Safety and efficacy of low-potassium dialysate. Am J Kidney Dis 1989; 13: 137-143.
23. De Nicola L, Bellizzi V, Minutolo R, Cioffi M, Giannattasio P, Terracciano V, Iodice C, Uccello F, Memoli B, Iorio BR, Conte G: Effect of dialysate sodium concentration on interdialytic increase of potassium. J Am Soc Nephrol 2000; 11: 2337-2343.
24. Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P: Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359: 7-20.
25. Locatelli F, Pontoriero G, Di Filippo S: Electrolyte disorders and substitution fluid in continuous renal replacement therapy. Kidney Int SUPPL 1998; 66:S151-S155.
26. Tan HK, Bellomo R, M'Pisi DA, Ronco C: Ionized serum calcium levels during acute renal failure: Intermittent hemodialysis vs continuous hemodiafiltration. Ren Fail 2002; 24: 19-27.
27. Morimatsu H, Uchino S, Bellomo R, Ronco C: Continuous veno-venous hemodiafiltration or hemofiltration: Impact on calcium, phosphate and magnesium concentrations. Int J Artif Organs 2002; 25: 512-519.
28. Troyanov S, Geadah D, Ghannoum M, Cardinal J, Leblanc M: Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy. Intensive Care Med 2004; 30: 1662-1665.
29. Santiago MJ, Lopez-Herce J, Urbano J, Bellon JM, del Castillo J, Carrillo A: Hypophosphatemia and phosphate SUPPLementation during continuous renal replacement therapy in children. Kidney Int 2009; 75: 312-316.
30. Bouchard J, Madore F: Role of citrate and other methods of anticoagulation in patients with severe liver failure requiring continuous renal replacement therapy. NDT Plus 2009; 1: 11-19.
31. Zhang Z, Hongying N: Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy. Intensive Care Med 2012; 38: 20-28.
32. Meier-Kriesche HU, Gitomer J, Finkel K, DuBose T: Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 2001; 29: 748-752.
33. Bihorac A, Ross EA: Continuous venovenous hemofiltration with citrate-based replacement fluid: Efficacy, safety, and impact on nutrition. Am J Kidney Dis 2005; 46: 908-918.
34. Aman J, Nurmohamed SA, Vervloet MG, Groeneveld AB: Metabolic effects of citratevs bicarbonate-based substitution fluid in continuous venovenous hemofiltration: A prospective sequential cohort study. J Crit Care 2010; 25: 120-127.